SCHEMBL11993064

SCHEMBL11993064

COc1cc(Oc2ccc(Br)c(C=O)c2)ccc1C(C)=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.45
ALDH1A1 P00352 3/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
MAPT P10636 4/20 0.42
KMT2A Q03164 2/20 0.42
ERN1 O75460 3/20 0.41
NPC1 O15118 1/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
HPGD P15428 2/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
TNFRSF1A P19438 1/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2531277 0.84 ERN1 (0.48) PRKDCALDH1A1PDE4APDE4BPDE4C
SCHEMBL7857299 0.83 PRKDC (0.57) PRKDCALDH1A1MAPTERN1HPGD
SCHEMBL7865553 0.78 ALDH1A1 (0.51) PRKDCALDH1A1MAPTERN1HPGD
SCHEMBL11993065 0.77 PDE4A (0.38) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL11993070 0.76 MAOB (0.34) PRKDCALDH1A1PDE4BERN1HPGD
Peonol Methyl Ether SCHEMBL29402500 0.75 ALDH1A1 (0.67) ALDH1A1PDE4APDE4BPDE4CPDE4D
Peonol Methyl Ether SCHEMBL246262 0.75 ALDH1A1 (0.67) ALDH1A1PDE4APDE4BPDE4CPDE4D
Peonol Methyl Ether SCHEMBL4700333 0.75 ALDH1A1 (0.67) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL584683 0.75 ERN1 (0.61) PRKDCALDH1A1MAPTKMT2AERN1
SCHEMBL15756665 0.75 ABCG2 (0.53) ALDH1A1MAPTKMT2ANPC1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160318955-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents ANACOR PHARMACEUTICALS, INC. 2016-11-03 US disclosed
US-9416146-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2016-08-16 US disclosed
US-20150291629-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents ANACOR PHARMACEUTICALS, LLC 2015-10-15 US disclosed
US-9012431-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2015-04-21 US disclosed
US-20140011768-A1 BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS ANACOR PHARMACEUTICALS, LLC 2014-01-09 US disclosed
US-8461135-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
US-20120214765-A1 BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS ANACOR PHARMACEUTICALS, INC. (US) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140011768-A1 BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS NFKBIA, LITAF, CD68 PRKDC 3894/4885ALDH1A1 3761/4885PDE4A 1019/4885
US-20160318955-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents NFKBIA, LITAF, CD68 PRKDC 3894/4885ALDH1A1 3761/4885PDE4A 1019/4885
US-20150291629-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents NFKBIA, LITAF, CD68 PRKDC 3894/4885ALDH1A1 3761/4885PDE4A 1019/4885
US-20120214765-A1 BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS NFKBIA, LITAF, CD68 PRKDC 3894/4885ALDH1A1 3761/4885PDE4A 1019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.